Pain, PostoperativePhase 4NCT04700228
Comparison of Doses of Dexmedetomidine With Bupivacaine in Caudal Block for Duration of Analgesia in Paediatric Infraumblical Surgeries.
A Phase 4 study testing Bupivacaine Hydrochloride and Dexmedetomidine in people with Pain, Postoperative, run by Dr. Ruth K.M. Pfau Civil Hospital, Karachi at 1 site in Pakistan.
Trial summary
Various methods are used to control post-operative pain among children. Amongst these methods, caudal block is one of the most favoured, prominent and dependable methods for providing reliable analgesia in surgeries below umbilicus. Read more about this study
- Who is it for?
- Ages 1 year to 6 yearsHealthy volunteers can take part
- Conditions the study is for
- Pain, Postoperative
- What is being tested?
- Bupivacaine Hydrochloride and Dexmedetomidine
- Could I receive a placebo?
- Yes, some participants may receive a placebo
- How many people
- 162 participants
- Where
- 1 sitePakistan
- Study dates
- Feb 2021to Sep 2021
- Phase
- Phase 4
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 1 year to 6 years
- All sexes
- Healthy volunteers accepted
- Child
Who may be able to join
- American Society of Anaesthesiologists (ASA) Status I and II
- Aged between 1 to 6 years
- Planned for below umbilicus elective surgery
Who cannot join
- Refusal to consent by parent/guardian
- Injection site infection
- Coagulation disorders
- Congenital abnormalities of lower spine and meninges
- Anticipated difficult airway requiring endotracheal intubation and intermittent positive pressure ventilation
- Prone position surgical procedures
- Known drug allergy history
Trial locations and contacts
1 site in 1 country.
About this study
Various methods are used to control post-operative pain among children. Amongst these methods, caudal block is one of the most favoured, prominent and dependable methods for providing reliable analgesia in surgeries below umbilicus.
This study is to compare two doses of Dexmedetomidine added as adjunct to local anaesthesia using reduced dose in caudal block for prolonging the duration of analgesia. Our secondary outcomes will include blood pressure, heart rate, urinary retention, nausea and vomiting in the paediatric population.
Read the detailed description
Pain is one the most underrated, misunderstood and often underdiagnosed field especially in children. Pain is an unpleasant feeling which is basically a subjective feeling, which in children is poorly expressed. Failure to control pain during childhood ultimately results in having chronic adverse effects which include altered sleep, eating habits and neuroendocrine responses and increased sensitivity to pain in the following pain episodes.
Successful postoperative pain management is one of the main pillars of anaesthesia. Regional Anaesthesia has gained a lot of popularity over the past few years in paediatrics. Approximately one-quarter of analgesic procedures currently performed on children are done by regional analgesic techniques. There are various methods that are being currently used to control post-operative pain among children. Amongst these methods, caudal block is one of the most favoured, prominent and dependable methods for providing reliable analgesia in surgeries below umbilicus. However, it has a drawback of being having a limited time of action when used as a single shot technique. This time limit can be increased significantly by the addition of different adjuvants along with local anaesthetic drugs in caudal block, which not only helps the anaesthesiologist in giving a better quality of anaesthesia and analgesia but it leads up to creating a desirable intraoperative environment for the surgeon as well. Better control over intraoperative and post-operative analgesia also helps the anaesthesiologist in giving reduced levels of anaesthesia which caused reduced amount of postoperative sedation as well.
Dexmedetomidine has a specific affinity for α2-adrenoreceptor having sedative and analgesic properties, which makes it an ideal adjuvant agent. The landmark ability of this adjuvant is that it causes minimal respiratory depression even at high dosages. A number of studies have been done until now that have proved successfully that dexmedetomidine can be used as an adjuvant in caudal block, in children, in enhancing post-operative analgesia. Although there is insufficient data available, various studies have demonstrated the dose of dexmedetomidine in Caudal Block ranging from 0.5 µg/kg to 2 µg/kg. According to an up to date review anaesthesia will last longer with dexmedetomidine as compared to morphine when used, as haemodynamics were found to be stable mostly when dexmedetomidine was used. However bradycardia was mostly related to a dose of 2 mcg/kg of dexmedetomidine. A study published in 2019 documented a decrease in heart rate, not requiring active management, in the dexmedetomidine group at a dose of 1mcg/kg.
Our objective is to compare two doses of Dexmedetomidine added as adjunct to local anaesthesia using reduced dose in caudal block for prolonging the duration of analgesia. Our secondary outcomes will include blood pressure, heart rate, urinary retention, nausea and vomiting in the paediatric population.
Patient meeting inclusion criteria visiting paediatric operating room will be inducted in the study. Informed and written consent will be taken from parents/guardian explained about the potential risk and benefits of study. Patients' demographic details like age, sex, and weight will be collected by filling the relevant proforma. A total of 162 patients will be divided into three equal groups randomly by lottery method. The observer and the anaesthesiologist who will induce the patient will be blinded regarding the group in which the patient will be placed.
Pre operatively, a detailed history, examination and related laboratory investigations will be seen as a part of hospital pre-operative assessment protocol. On arrival to operation theatre, monitors (SpO2, Pulse Oximeter, NIBP, pre cordial stethoscope and ECG) will be applied. Emergency drugs will be prepared already before the patient arrives in operation theatre. Anaesthesia will be induced with 100% oxygen and sevoflurane 8% using Jackson Rees Circuit. Once the desired depth of anaesthesia is achieved, I/V access will be taken. Propofol 3mg/kg and Nalbuphine 0.1mg/kg will be given and Sevoflurane will be set at 3%. LMA of desirable size will be placed. After this, patient would be placed in lateral position. Sufficient exposure would be done for Caudal Block. After taking all aseptic measures, Caudal Block procedure will be done with help of 23G needle after identifying the anatomical landmarks. Correction position of the needle will be confirmed by swoosh and whoosh test. On aspiration of the syringe if it is negative for CSF and blood, then one of the following drug combinations will be used for the caudal block.
Group C (control): 0.25% bupivacaine at a total volume of 0.5ml/kg Group BD1: 0.25% bupivacaine + 1mcg/kg dexmedetomidine at a total volume of 0.5ml/kg Group BD2: 0.25% bupivacaine + 0.5mcg/kg dexmedetomidine at a total volume of 0.5ml/kg After dressing the injection site, the patient will be turned supine. Vitals of the patient including heart rate, blood pressure, SpO2 and respiratory will be recorded before the induction of caudal block and there after every 10 minutes. Inadequate analgesia or unsuccessful block will be labelled if there would be a 20% increase in heart rate of the patient as compared to the baseline recording. If the caudal block is insufficient that case will not be included in the study. Hypotension and bradycardia will be recorded and treated with fluid bolus and atropine respectively. . The first surgical incision would be given 10 mins after the application of caudal block. After the completion of the surgery, inhalation gas will be closed and patient will be given 100% oxygen only. LMA will be removed once the patient is awake and the patient will be shifted to Post Anaesthesia Care Unit (PACU). Here patient's vitals will be monitored and pain will be assessed at 1, 2, 4, 6 and 12 hours after the application of caudal block using FLACC scale16. Time taken for the requirement of first rescue analgesia will also be recorded. Intravenous paracetamol 15mg/kg will be given if FLACC score is more than 4 at any of the above mentioned time. Secondary findings like heart rate, blood pressure, respiratory depression, urinary retention, nausea and vomiting will also be recorded.
- Conditions
- Pain, Postoperative
- Being tested
- Bupivacaine Hydrochloride, Dexmedetomidine
- Keywords
- Postoperative pain, Regional Anaesthesia, Caudal Block, Dexmedetomidine, Infraumbilical surgeries
- Medical subject headings
- Pain, Postoperative
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Bupivacaine HydrochlorideDrug
We are going to see the effects of dexmedetomidine as an adjunct to bupivacaine in caudal block. In first (control) group (group C) only bupivacaine will be given. Group BD1 patients will be given bupivacaine plus 1mcg/kg dexmedetomidine. Group BD2 patients will get bupivacaine plus 0.5mcg/kg dexmedetomidine. All the groups will be given a volume of 0.5ml/kg.
DexmedetomidineDrug
We are going to see the effects of dexmedetomidine as an adjunct to bupivacaine in caudal block. In first (control) group (group C) only bupivacaine will be given. Group BD1 patients will be given bupivacaine plus 1mcg/kg dexmedetomidine. Group BD2 patients will get bupivacaine plus 0.5mcg/kg dexmedetomidine. All the groups will be given a volume of 0.5ml/kg.
| Study group | Role | What they receive |
|---|---|---|
| Group C | Placebo comparator | 0.25% bupivacaine at a total volume of 0.5ml/kg. Receives: Drug: Bupivacaine Hydrochloride |
| Group BD1 | Active comparator | 0.25% bupivacaine + 1mcg/kg dexmedetomidine at a total volume of 0.5ml/kg. Receives: Drug: Bupivacaine Hydrochloride; Drug: Dexmedetomidine |
| Group BD2 | Active comparator | 0.25% bupivacaine + 0.5mcg/kg dexmedetomidine at a total volume of 0.5ml/kg. Receives: Drug: Bupivacaine Hydrochloride; Drug: Dexmedetomidine |
What is being measured
The primary outcome is the main question the study is designed to answer.
Duration of Analgesia
Time period between administration of block until the time face, legs, activity, cry, consolability (FLACC) score reached ≥4
Measured: 1 hour after caudal block
Duration of Analgesia
Time period between administration of block until the time face, legs, activity, cry, consolability (FLACC) score reached ≥4
Measured: 2 hours after caudal block
Duration of Analgesia
Time period between administration of block until the time face, legs, activity, cry, consolability (FLACC) score reached ≥4
Measured: 4 hours after caudal block
Duration of Analgesia
Time period between administration of block until the time face, legs, activity, cry, consolability (FLACC) score reached ≥4
Measured: 6 hours after caudal block
Duration of Analgesia
Time period between administration of block until the time face, legs, activity, cry, consolability (FLACC) score reached ≥4
Measured: 12 hours after caudal block
Secondary outcomes (15)
Heart Rate (bradycardia)
heart rate less than 60 beats/min for ages above 1 year.
Measured: 1 hour after caudal block.
Heart Rate (bradycardia)
heart rate less than 60 beats/min for ages above 1 year.
Measured: 2 hours after caudal block.
Heart Rate (bradycardia)
heart rate less than 60 beats/min for ages above 1 year.
Measured: 4 hours after caudal block.
Heart Rate (bradycardia)
heart rate less than 60 beats/min for ages above 1 year.
Measured: 6 hours after caudal block.
Heart Rate (bradycardia)
heart rate less than 60 beats/min for ages above 1 year.
Measured: 12 hours after caudal block.
Blood Pressure
Decrease in systolic blood pressure < 25% from the baseline
Measured: 1 hour after caudal block.
Blood Pressure
Decrease in systolic blood pressure < 25% from the baseline
Measured: 2 hours after caudal block.
Blood Pressure
Decrease in systolic blood pressure < 25% from the baseline
Measured: 4 hours after caudal block.
Blood Pressure
Decrease in systolic blood pressure < 25% from the baseline
Measured: 6 hours after caudal block.
Blood Pressure
Decrease in systolic blood pressure < 25% from the baseline
Measured: 12 hours after caudal block.
Postoperative Respiratory Depression
if the SpO2 is less than 95% or breathing rate is less than 10 breaths per minute.
Measured: 1 hour after caudal block.
Postoperative Respiratory Depression
if the SpO2 is less than 95% or breathing rate is less than 10 breaths per minute.
Measured: 2 hours after caudal block.
Postoperative Respiratory Depression
if the SpO2 is less than 95% or breathing rate is less than 10 breaths per minute.
Measured: 4 hours after caudal block.
Postoperative Respiratory Depression
if the SpO2 is less than 95% or breathing rate is less than 10 breaths per minute.
Measured: 6 hours after caudal block.
Postoperative Respiratory Depression
if the SpO2 is less than 95% or breathing rate is less than 10 breaths per minute.
Measured: 12 hours after caudal block.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted7 Jan 2021
- Study startFeb 2021 (estimated)
- Primary completionJun 2021 (estimated)
- Study completionSep 2021 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Pain, PostoperativeStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase 4
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Factorial
- Model description
- Factorial Assignment Anesthesia will be induced with 100% oxygen and sevoflurane 8%. Once achieving the desired depth of anesthesia, I/V access will be taken. Propofol 3mg/kg and Nalbuphine 0.1mg/kg will be given. LMA of desirable size will be placed. After this, patient would be placed in lateral position for caudal Block. After all aseptic measures, Caudal Block procedure will be done with help of 23G needle by anatomical landmarks. On negative aspiration of the syringe, one of the drug combinations as explained under 'arms and intervention' will be used for the caudal block. First surgical incision will be given 10 mins after the application of caudal block. After the completion of surgery, LMA will be removed once the patient is awake and the patient will be shifted to PACU. IV paracetamol 15mg/kg will be given if FLACC score is more than 4 at any point during the surgery.
- Masking
- Double blind
- Who is masked
- Participant, Care provider
- Enrolment
- 162 participants (actual)
Sponsor and investigators
- Lead sponsor
- Dr. Ruth K.M. Pfau Civil Hospital, Karachi
- Sponsor type
- Other government
- Responsible party
- Principal investigator, Haris Chohan, Dr. Ruth K.M. Pfau Civil Hospital, Karachi
- Investigators
- Haris Chohan, FCPS Pakistan, Principal investigator, Dr. Ruth KM Pfau Civil Hospital, Dow University of Health Sciences Karachi, PakistanSyed Farjad Sultan, FCARCSI, PhD, Principal investigator, Dr. Ruth KM Pfau Civil Hospital, Dow University of Health Sciences Karachi, PakistanArun Kumar, FCPS, Principal investigator, Dr. Ruth KM Pfau Civil Hospital, Dow University of Health Sciences, Karachi, Pakistan
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04700228
- Sponsor's protocol ID
- Haris123
- Status last verified
- Jan 2021
- First submitted
- 6 Jan 2021
- Last updated
- 7 Jan 2021
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 7 Jan 2021. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Comparison of Doses of Dexmedetomidine With Bupivacaine in Caudal Block for Duration of Analgesia in Paediatric Infraumblical Surgeries.
- ClinicalTrials.gov ID
- NCT04700228
- Acronym / sponsor ID
- Haris123
- Conditions
- Pain, Postoperative
- Keywords
- Postoperative pain, Regional Anaesthesia, Caudal Block, Dexmedetomidine, Infraumbilical surgeries
- Phase
- Phase 4
- Study type
- Interventional
- Recruitment status
- Unknown status
- Enrolment
- 162 participants (actual)
- Lead sponsor
- Dr. Ruth K.M. Pfau Civil Hospital, KarachiOther government
- Study start
- Feb 2021 (estimated)
- Primary completion
- Jun 2021 (estimated)
- Study completion
- Sep 2021 (estimated)
- First posted
- 7 Jan 2021 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Various methods are used to control post-operative pain among children. Amongst these methods, caudal block is one of the most favoured, prominent and dependable methods for providing reliable analgesia in surgeries below umbilicus.
This study is to compare two doses of Dexmedetomidine added as adjunct to local anaesthesia using reduced dose in caudal block for prolonging the duration of analgesia. Our secondary outcomes will include blood pressure, heart rate, urinary retention, nausea and vomiting in the paediatric population.
Detailed description
Pain is one the most underrated, misunderstood and often underdiagnosed field especially in children. Pain is an unpleasant feeling which is basically a subjective feeling, which in children is poorly expressed. Failure to control pain during childhood ultimately results in having chronic adverse effects which include altered sleep, eating habits and neuroendocrine responses and increased sensitivity to pain in the following pain episodes.
Successful postoperative pain management is one of the main pillars of anaesthesia. Regional Anaesthesia has gained a lot of popularity over the past few years in paediatrics. Approximately one-quarter of analgesic procedures currently performed on children are done by regional analgesic techniques. There are various methods that are being currently used to control post-operative pain among children. Amongst these methods, caudal block is one of the most favoured, prominent and dependable methods for providing reliable analgesia in surgeries below umbilicus. However, it has a drawback of being having a limited time of action when used as a single shot technique. This time limit can be increased significantly by the addition of different adjuvants along with local anaesthetic drugs in caudal block, which not only helps the anaesthesiologist in giving a better quality of anaesthesia and analgesia but it leads up to creating a desirable intraoperative environment for the surgeon as well. Better control over intraoperative and post-operative analgesia also helps the anaesthesiologist in giving reduced levels of anaesthesia which caused reduced amount of postoperative sedation as well.
Dexmedetomidine has a specific affinity for α2-adrenoreceptor having sedative and analgesic properties, which makes it an ideal adjuvant agent. The landmark ability of this adjuvant is that it causes minimal respiratory depression even at high dosages. A number of studies have been done until now that have proved successfully that dexmedetomidine can be used as an adjuvant in caudal block, in children, in enhancing post-operative analgesia. Although there is insufficient data available, various studies have demonstrated the dose of dexmedetomidine in Caudal Block ranging from 0.5 µg/kg to 2 µg/kg. According to an up to date review anaesthesia will last longer with dexmedetomidine as compared to morphine when used, as haemodynamics were found to be stable mostly when dexmedetomidine was used. However bradycardia was mostly related to a dose of 2 mcg/kg of dexmedetomidine. A study published in 2019 documented a decrease in heart rate, not requiring active management, in the dexmedetomidine group at a dose of 1mcg/kg.
Our objective is to compare two doses of Dexmedetomidine added as adjunct to local anaesthesia using reduced dose in caudal block for prolonging the duration of analgesia. Our secondary outcomes will include blood pressure, heart rate, urinary retention, nausea and vomiting in the paediatric population.
Patient meeting inclusion criteria visiting paediatric operating room will be inducted in the study. Informed and written consent will be taken from parents/guardian explained about the potential risk and benefits of study. Patients' demographic details like age, sex, and weight will be collected by filling the relevant proforma. A total of 162 patients will be divided into three equal groups randomly by lottery method. The observer and the anaesthesiologist who will induce the patient will be blinded regarding the group in which the patient will be placed.
Pre operatively, a detailed history, examination and related laboratory investigations will be seen as a part of hospital pre-operative assessment protocol. On arrival to operation theatre, monitors (SpO2, Pulse Oximeter, NIBP, pre cordial stethoscope and ECG) will be applied. Emergency drugs will be prepared already before the patient arrives in operation theatre. Anaesthesia will be induced with 100% oxygen and sevoflurane 8% using Jackson Rees Circuit. Once the desired depth of anaesthesia is achieved, I/V access will be taken. Propofol 3mg/kg and Nalbuphine 0.1mg/kg will be given and Sevoflurane will be set at 3%. LMA of desirable size will be placed. After this, patient would be placed in lateral position. Sufficient exposure would be done for Caudal Block. After taking all aseptic measures, Caudal Block procedure will be done with help of 23G needle after identifying the anatomical landmarks. Correction position of the needle will be confirmed by swoosh and whoosh test. On aspiration of the syringe if it is negative for CSF and blood, then one of the following drug combinations will be used for the caudal block.
Group C (control): 0.25% bupivacaine at a total volume of 0.5ml/kg Group BD1: 0.25% bupivacaine + 1mcg/kg dexmedetomidine at a total volume of 0.5ml/kg Group BD2: 0.25% bupivacaine + 0.5mcg/kg dexmedetomidine at a total volume of 0.5ml/kg After dressing the injection site, the patient will be turned supine. Vitals of the patient including heart rate, blood pressure, SpO2 and respiratory will be recorded before the induction of caudal block and there after every 10 minutes. Inadequate analgesia or unsuccessful block will be labelled if there would be a 20% increase in heart rate of the patient as compared to the baseline recording. If the caudal block is insufficient that case will not be included in the study. Hypotension and bradycardia will be recorded and treated with fluid bolus and atropine respectively. . The first surgical incision would be given 10 mins after the application of caudal block. After the completion of the surgery, inhalation gas will be closed and patient will be given 100% oxygen only. LMA will be removed once the patient is awake and the patient will be shifted to Post Anaesthesia Care Unit (PACU). Here patient's vitals will be monitored and pain will be assessed at 1, 2, 4, 6 and 12 hours after the application of caudal block using FLACC scale16. Time taken for the requirement of first rescue analgesia will also be recorded. Intravenous paracetamol 15mg/kg will be given if FLACC score is more than 4 at any of the above mentioned time. Secondary findings like heart rate, blood pressure, respiratory depression, urinary retention, nausea and vomiting will also be recorded.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Factorial
- Masking
- Double blind (participant, care provider)
- Number of arms
- 3
- Model description
- Factorial Assignment Anesthesia will be induced with 100% oxygen and sevoflurane 8%. Once achieving the desired depth of anesthesia, I/V access will be taken. Propofol 3mg/kg and Nalbuphine 0.1mg/kg will be given. LMA of desirable size will be placed. After this, patient would be placed in lateral position for caudal Block. After all aseptic measures, Caudal Block procedure will be done with help of 23G needle by anatomical landmarks. On negative aspiration of the syringe, one of the drug combinations as explained under 'arms and intervention' will be used for the caudal block. First surgical incision will be given 10 mins after the application of caudal block. After the completion of surgery, LMA will be removed once the patient is awake and the patient will be shifted to PACU. IV paracetamol 15mg/kg will be given if FLACC score is more than 4 at any point during the surgery.
| Arm | Type | Receives |
|---|---|---|
| Group C | Placebo comparator | Drug: Bupivacaine Hydrochloride0.25% bupivacaine at a total volume of 0.5ml/kg. |
| Group BD1 | Active comparator | Drug: Bupivacaine Hydrochloride, Drug: Dexmedetomidine0.25% bupivacaine + 1mcg/kg dexmedetomidine at a total volume of 0.5ml/kg. |
| Group BD2 | Active comparator | Drug: Bupivacaine Hydrochloride, Drug: Dexmedetomidine0.25% bupivacaine + 0.5mcg/kg dexmedetomidine at a total volume of 0.5ml/kg. |
Who may qualify
- Ages
- 1 year to 6 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Child
Key inclusion criteria (3 listed)
- American Society of Anaesthesiologists (ASA) Status I and II
- Aged between 1 to 6 years
- Planned for below umbilicus elective surgery
Key exclusion criteria (7 listed)
- Refusal to consent by parent/guardian
- Injection site infection
- Coagulation disorders
- Congenital abnormalities of lower spine and meninges
- Anticipated difficult airway requiring endotracheal intubation and intermittent positive pressure ventilation
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Bupivacaine HydrochlorideWe are going to see the effects of dexmedetomidine as an adjunct to bupivacaine in caudal block. In first (control) group (group C) only bupivacaine will be given. Group BD1 patients will be given bupivacaine plus 1mcg/kg dexmedetomidine. Group BD2 patients will get bupivacaine plus 0.5mcg/kg dexmedetomidine. All the groups will be given a volume of 0.5ml/kg. | Drug | Group BD1, Group BD2, Group C |
| DexmedetomidineWe are going to see the effects of dexmedetomidine as an adjunct to bupivacaine in caudal block. In first (control) group (group C) only bupivacaine will be given. Group BD1 patients will be given bupivacaine plus 1mcg/kg dexmedetomidine. Group BD2 patients will get bupivacaine plus 0.5mcg/kg dexmedetomidine. All the groups will be given a volume of 0.5ml/kg. | Drug | Group BD1, Group BD2 |
Primary outcome
Duration of Analgesia
Time frame: 1 hour after caudal block
Time period between administration of block until the time face, legs, activity, cry, consolability (FLACC) score reached ≥4
Duration of Analgesia
Time frame: 2 hours after caudal block
Time period between administration of block until the time face, legs, activity, cry, consolability (FLACC) score reached ≥4
Duration of Analgesia
Time frame: 4 hours after caudal block
Time period between administration of block until the time face, legs, activity, cry, consolability (FLACC) score reached ≥4
Duration of Analgesia
Time frame: 6 hours after caudal block
Time period between administration of block until the time face, legs, activity, cry, consolability (FLACC) score reached ≥4
Duration of Analgesia
Time frame: 12 hours after caudal block
Time period between administration of block until the time face, legs, activity, cry, consolability (FLACC) score reached ≥4
15 secondary outcomes
Heart Rate (bradycardia)
Time frame: 1 hour after caudal block.
Heart Rate (bradycardia)
Time frame: 2 hours after caudal block.
Heart Rate (bradycardia)
Time frame: 4 hours after caudal block.
Heart Rate (bradycardia)
Time frame: 6 hours after caudal block.
Heart Rate (bradycardia)
Time frame: 12 hours after caudal block.
Blood Pressure
Time frame: 1 hour after caudal block.
Blood Pressure
Time frame: 2 hours after caudal block.
Blood Pressure
Time frame: 4 hours after caudal block.
Blood Pressure
Time frame: 6 hours after caudal block.
Blood Pressure
Time frame: 12 hours after caudal block.
Postoperative Respiratory Depression
Time frame: 1 hour after caudal block.
Postoperative Respiratory Depression
Time frame: 2 hours after caudal block.
Postoperative Respiratory Depression
Time frame: 4 hours after caudal block.
Postoperative Respiratory Depression
Time frame: 6 hours after caudal block.
Postoperative Respiratory Depression
Time frame: 12 hours after caudal block.
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 7 Jan 2021.
Related trials for Pain, Postoperative
RecruitingPhase 4
ESP Blocks for Posterior Spinal Fusion
Postoperative Pain
Recruiting
Effect of Cryotherapeutic and Nanotherapeutic Sodium Hypochlorite on Post-Operative Endodontic Pain.
Symptomatic Irreversible Pulpitis, Symptomatic Apical Periodontitis
RecruitingPhase 2
REctus Sheath Trial
Acute Pain, Postoperative Pain, Acute
Not yet recruiting
Effect of Pectoral Nerve Block (PECS) Using Magnesium Sulfate Added to Dexamethasone on Quality of Recovery and Chronic Post-Mastectomy Pain
Breast Cancer, Postoperative Pain
Active, not recruitingPhase 4
Effect of Dexmedetomidine on Postoperative Pain in Spinal Anesthesia for Cesarean Section at Assuit University Hospital
Cesarean Section
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Haris Chohan, FCPS Pakistan principal investigator
Dr. Ruth KM Pfau Civil Hospital, Dow University of Health Sciences Karachi, Pakistan
Syed Farjad Sultan, FCARCSI, PhD principal investigator
Dr. Ruth KM Pfau Civil Hospital, Dow University of Health Sciences Karachi, Pakistan
Arun Kumar, FCPS principal investigator
Dr. Ruth KM Pfau Civil Hospital, Dow University of Health Sciences, Karachi, Pakistan
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A Phase 4 study testing Bupivacaine Hydrochloride and Dexmedetomidine in people with Pain, Postoperative, run by Dr. Ruth K.M. Pfau Civil Hospital, Karachi at 1 site in Pakistan.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 7 Jan 2021. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Pakistan. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
What does this phase mean?
Phase 4 studies take place after a treatment is approved, to learn more about its long-term benefits and risks in everyday use.
Not every study follows the same path, and some studies (observational studies, device studies) have no phase.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Duration of Analgesia (time frame: 1 hour after caudal block). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Jan 2021.